Urinary leukotriene E4 and prostaglandin F2a concentrations in children with migraine: a randomized study.
OBJECTIVE
Pro-inflammatory mediators are thought to play both peripheral and central roles in migraine pathophysiology. Prostaglandins and leukotrienes, known as the eicosanoids, are degradation products of arachidonic acid and constitute signalization components of inflammatory pathways. This study was designed to assess concentrations of leukotriene E4 (LT-E4) and prostaglandin F2a (PG-F2a) in children with migraine.


METHODS
This study involved patients aged ≤18 years who presented to the Ondokuz Mayis University Children's Hospital with migrainous headache between January and October 2011. Urinary LT-E4 and PG-F2a concentrations were measured in patients during a headache episode and at a headache-free time and in a control group.


RESULTS
The patient group consisted of 38 girls and 26 boys aged 5-18 years diagnosed with migraine and having at least 6 months of headache, whereas the control group consisted of 21 girls and 29 boys. Mean ± standard deviation (SD) urinary LT-E4 concentrations were significantly higher in patients during a migraine episode than in controls (1466.8±1052.5 pg/ml vs 811.6±460.0 pg/ml, P<0.001). In patients with migraine, both urinary LT-E4 (P<0.001) and PG-F2a (P=0.021) levels were significantly higher during headache than during non-headache periods.


CONCLUSIONS
Urinary LT-E4 and PG-F2a were both significantly higher in children with migraine during headache than during non-headache periods. The elevation in the levels of these inflammatory mediators was compatible with the hypothesis relating neuroinflammation in trigeminal vascular blood vessels with migraine pathophysiology. Leukotriene antagonists may be effective in the prophylaxis of migraine attacks.
Department of Pediatric Neurology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey.
H
H
Ince
Ö F
ÖF
Aydin
H
H
Alaçam
T
T
Aydin
E
E
Azak
H
H
Özyürek
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D015237:Dinoprost / Q000652:urine*; D005260:Female; D006801:Humans; D017999:Leukotriene E4 / Q000652:urine*; D008297:Male; D008881:Migraine Disorders / Q000503:physiopathology* / Q000652:urine*
D017999:Leukotriene E4; D015237:Dinoprost
migraine; urinary leukotriene E4; urinary prostaglandin F2a